Connect with us

Australia

Infamous Bondi hoarder who plagued her neighbours with piles of rubbish FINALLY gets a clean-up

Published

on

infamous bondi hoarder who plagued her neighbours with piles of rubbish finally gets a clean up

A notorious hoarder from Sydney’s affluent east who fought for decades to keep her loot scattered outside her home has finally submitted to a council clean up.

Mary Bobolas, 79, and her family have spent the past two decades defending the mountains of rubbish strewn in and around her home in Sydney’s Bondi Beach.

Their tussle with the Waverley Council took a turn on Tuesday, when workers were seen cleaning up the front yard of her home on Boonara Avenue.

Ms Bobolas was at the site along with police and volunteers after an order was issued by the Land and Environment Court.

Waverley Council have commenced a clean up at Mary Bobolas' home in Bondi (pictured on Tuesday)

Waverley Council have commenced a clean up at Mary Bobolas' home in Bondi (pictured on Tuesday)

Waverley Council have commenced a clean up at Mary Bobolas’ home in Bondi (pictured on Tuesday)

Workers were spotted sorting through rubbish outside of Ms Bobolas' home on Tuesday (pictured)

Workers were spotted sorting through rubbish outside of Ms Bobolas' home on Tuesday (pictured)

Workers were spotted sorting through rubbish outside of Ms Bobolas’ home on Tuesday (pictured)

‘Council has repeatedly offered support to the family but this support has been refused,’ a Waverley Council spokesperson told Daily Mail Australia.

‘We understand this matter also presents a difficult situation for residents and we appreciate their patience and understanding.’

Ms Bobolas along with her daughters Elena and Liana have made headlines as being among Australia’s most notorious hoarders.

The 79-year-old bought the home in 1973 for $15,000 just minutes from the beach, but it could likely be worth several million dollars in today’s property market.

The Spanish-born pensioner has had her home pulled from the market at least three times after covering clean-up costs at the last minute to keep her property.

Police attended the clean up at Waverley Council’s request, but had no involvement in the day’s affairs.

Ms Bobolas (pictured) was at the site with police and volunteers after an order was issued

Ms Bobolas (pictured) was at the site with police and volunteers after an order was issued

Ms Bobolas (pictured) was at the site with police and volunteers after an order was issued

The council have conducted about 15 clean ups at the site in the last 20 years with the most recent in February 2019.

The Waverley Council spokesperson said the Bobolas family have the right to appeal the clean up.

‘During the clean-up, an assessment will also be made about the requirements and logistics associated with other orders relating to the property including removal of the garage and its contents, access to the house to assess a tree growing through it and an order relating to the safety of the rear verandah,’ they said. 

‘Council is committed to ensuring the health and safety of Waverley as a whole and will continue to pursue the matter through the channels available to us as a Council until there is a satisfactory resolution.’

Police attended the clean up at Waverley Council's request, but had no involvement in the day's affairs

Police attended the clean up at Waverley Council's request, but had no involvement in the day's affairs

Police attended the clean up at Waverley Council’s request, but had no involvement in the day’s affairs

This post first appeared on dailymail.co.uk

Australia

Coronavirus US: Trump administration to pay $375m for antibody drug

Published

on

By

coronavirus us trump administration to pay 375m for antibody drug

The US government will play Eli Lilly & Co more than $1 billion in exchange for about one million doses of its experimental coronavirus antibody treatment.

It’s the latest move by the Trump administration as it stocks up on vaccine and drugs in an attempt to tame the pandemic that has killed more than 225,00 Americans.   

Lilly will start delivering 300,000 doses of the antibody, LY-CoV55, also known as bamlanivimab, for which it is being paid $375 million, if it receives Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).

The price per dose amounts to $1,250 as per the contract, but the vials purchased by the government will be free to the American public. 

The news come after the drugmaker ended its clinical trial of the antibody and remdesivir after the National Institutes of Health found the combination failed to help recovery of hospitalized patients. 

The US government will play Eli Lilly & Co $375 million in exchange for 300,000 doses of its experimental coronavirus antibody treatment. Pictured: An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, May 2020

The US government will play Eli Lilly & Co $375 million in exchange for 300,000 doses of its experimental coronavirus antibody treatment. Pictured: An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, May 2020

The US government will play Eli Lilly & Co $375 million in exchange for 300,000 doses of its experimental coronavirus antibody treatment. Pictured: An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, May 2020

Earlier this month, Lilly applied for emergency use with the FDA for the antibody as treatment for mildly and moderately ill COVID-19 patients. Pictured: The headquarters of Eli Lilly & Co stands in Indianapolis, June 2010

Earlier this month, Lilly applied for emergency use with the FDA for the antibody as treatment for mildly and moderately ill COVID-19 patients. Pictured: The headquarters of Eli Lilly & Co stands in Indianapolis, June 2010

Earlier this month, Lilly applied for emergency use with the FDA for the antibody as treatment for mildly and moderately ill COVID-19 patients. Pictured: The headquarters of Eli Lilly & Co stands in Indianapolis, June 2010

The initial agreement is for Lilly to deliver the doses over the two months following an EUA

It also provides the option for the government to buy an additional 650,000 vials for $812.5 million, the US Department of Health and Human Services said in a statement. 

‘Lilly has leveraged our deep scientific capability to fight this pandemic and we are proud of our efforts to develop potential medicines to combat COVID-19,’ said CEO David Ricks said in a statement.  

‘Supply agreements with governments – such as this one with the US government to meet Operation Warp Speed goals – are fundamental to enable the most widespread and equitable access to our potential therapy.’ 

The US has also signed deals with AstraZeneca and Regeneron Pharmaceuticals for their antibody therapies, under Trump administration’s Operation Warp Speed program.

The deal with Regeneron covers the cost of manufacturing, while the deal with AstraZeneca also includes support for development.

While vaccines are seen critical to ending the pandemic, governments are increasingly looking at other effective treatments to slow the spread of the virus and kick-start economic activity. 

Recently, Lilly filed a request for FDA approval to treat mild to moderately ill COVID-19 patients after promising results from a study.

Researchers found that hospitalization or ER visits occurred in 1.7 percent of 302 patients given the drug and six percent of those given the placebo, a 72 percent risk reduction.

No serious side effects or deaths were reported among patients.

34958378 8889287 image a 24 1603901424700

34958378 8889287 image a 24 1603901424700

34958372 8889287 image a 25 1603901434915

34958372 8889287 image a 25 1603901434915

34958364 8889287 image a 26 1603901438355

34958364 8889287 image a 26 1603901438355

The antibody therapy is similar to a drug from Regeneron that was given to Trump during his bout with COVID-19.

The treatments belong to a class of drugs called monoclonal antibodies that are manufactured copies of antibodies created by the body to fight against an infection.

Recently, Lilly was forced to end its clinical trial of an antibody drug early after it was shown to not help hospitalized coronavirus patients recover.  

The ACTIV-3 study was paused on October 13 due to ‘potential safety concerns’ and out of an ‘abundance of caution.’   

However, company officials have still not revealed what the safety concerns were, or how many hospitalized participants were affected, after a pause was recommended by an independent safety board.  

In a statement on Monday, the National Institutes of Health (NIH), which was sponsoring the trial, said the antibody treatment did not pose any safety risk.

However, investigators found that there was no significant difference in outcomes between patients getting Lilly’s drug and those receiving a placebo.     

34958374 8889287 image a 27 1603901460983

34958374 8889287 image a 27 1603901460983

34958370 8889287 image a 28 1603901465311

34958370 8889287 image a 28 1603901465311

The antibody therapy is similar to a drug from Regeneron that was given to Trump during his bout with COVID-19.

The treatments belong to a class of drugs called monoclonal antibodies that are manufactured copies of antibodies created by the body to fight against an infection.         

The company submitted a request to the U.S. Food and Drug Administration earlier this month for emergency use authorization of the drug to treat mild to moderate COVID-19 patients. The drug had a recent setback after it failed to show benefits in hospitalized patients.

In addition, Reuters reported that U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly plant that is ramping up to make its antibody therapy.

The antibody therapy is similar to a drug from Regeneron that was given to Trump during his bout with COVID-19.

The treatments belong to a class of drugs called monoclonal antibodies that are manufactured copies of antibodies created by the body to fight against an infection.3

This post first appeared on dailymail.co.uk

Continue Reading

Australia

‘World’s whitest shade of white paint’ may slow global warming

Published

on

By

worlds whitest shade of white paint may slow global warming

Researchers at Indiana’s Purdue University have manufactured the world’s whitest shade of paint – a creation they believe has the ability to slow the process of global warming

The team, led by mechanical engineer Xiulin Ruan, say the shade of white is so bright that it reflects 95.5 percent of sunlight that hits its surface. 

In a scientific paper published this month, the group proclaim that the bright paint could be applied to rooftops of buildings around the world to keep them naturally cool. 

As the sun would reflect most of its heat back off the top of the structures, buildings would no longer need expensive electrical air conditioners to keep their interiors at a moderate temperature. Air conditioning is often considered a huge contributor to greenhouse gas emissions.  

This process  of the sun reflecting back off of surfaces is known scientifically as ‘passive radiative cooling’.  

Researchers at Indiana's Purdue University have manufactured the world's whitest shade of paint - a creation they believe has the ability to slow the process of global warming. Research leader Xiulin Ruan is pictured left. The team is seen using an infrared camera to compare the cooling performance of white paint samples

Researchers at Indiana's Purdue University have manufactured the world's whitest shade of paint - a creation they believe has the ability to slow the process of global warming. Research leader Xiulin Ruan is pictured left. The team is seen using an infrared camera to compare the cooling performance of white paint samples

Researchers at Indiana’s Purdue University have manufactured the world’s whitest shade of paint – a creation they believe has the ability to slow the process of global warming. Research leader Xiulin Ruan is pictured left. The team is seen using an infrared camera to compare the cooling performance of white paint samples 

As the sun would reflect most of its heat back off the top of the structures, buildings would no longer need expensive electrical air conditioners to keep their interiors at a moderate temperature

As the sun would reflect most of its heat back off the top of the structures, buildings would no longer need expensive electrical air conditioners to keep their interiors at a moderate temperature

As the sun would reflect most of its heat back off the top of the structures, buildings would no longer need expensive electrical air conditioners to keep their interiors at a moderate temperature

The group’s research has demonstrated that their new shade of white paint – which does not yet have a name – can cool down surfaces by a whopping 18 degrees Fahrenheit. 

The paint is even cool to the touch.   

Prior to the group’s creation, the whitest shade of paint only managed to reflect between 80 and 90 percent of sunlight. 

What makes this paint different is that it features calcium carbonate (CaCO3)  – a chemical compound found in limestone, shells and chalk. 

Calcium carbonate is extremely abundant, meaning that this new white shade of paint is relatively cheap to produce. 

While the painting the surfaces of buildings in this new white paint may not be quite  as environmentally effective as installing solar panels, it will be significantly more cost effective.

An infrared camera image shows that white radiative cooling paint developed by Purdue University researchers (left, purple) can stay cooler in direct sunlight compared with commercial white paint

An infrared camera image shows that white radiative cooling paint developed by Purdue University researchers (left, purple) can stay cooler in direct sunlight compared with commercial white paint

An infrared camera image shows that white radiative cooling paint developed by Purdue University researchers (left, purple) can stay cooler in direct sunlight compared with commercial white paint

Graphs and images show how the group's new CaCO3 stayed cooler during direct exposure to the sunlight

Graphs and images show how the group's new CaCO3 stayed cooler during direct exposure to the sunlight

Graphs and images show how the group’s new CaCO3 stayed cooler during direct exposure to the sunlight 

‘Our paint is compatible with the manufacturing process of commercial paint, and the cost may be comparable or even lower,’ Ruan told Science Daily.

‘The key is to ensure the reliability of the paint so that it is viable in long-term outdoor applications.’

Ruan and his group of researchers say the cooling paint could even be applied to other objects, including cars and telecommunications equipment, such as 5G towers.  

However, there is one catch that environmentalists are still considering.  

The new white paint may be problematic during the colder months of the year if it is applied to rooftops and other surfaces. 

Given that the paint can keep temperatures up to 18 degrees cooler, some critics say heating costs and consumption will rise during winter months, meaning that the positive environmental impacts of decreased air conditioning would be cancelled out. 

The group's CaC03 white paint - which does not yet have an official name - is the whitest shade ever developed

The group's CaC03 white paint - which does not yet have an official name - is the whitest shade ever developed

The group’s CaC03 white paint – which does not yet have an official name – is the whitest shade ever developed 

This post first appeared on dailymail.co.uk

Continue Reading

Australia

Heartless dog owner leaves lurcher tied to lamppost with broken leg

Published

on

By

heartless dog owner leaves lurcher tied to lamppost with broken leg

A heartless dog owner abandoned his lurcher Steve leaving him tied to a bus stop with a broken leg.

Two-year-old Steve was spotted by a passerby on the street in Canterbury, Kent. 

They then alerted Dogs Trust, who took him to a nearby vet for emergency treatment. 

Steve was then moved to an RSPCA hospital for an operation to fix his front leg.   

Having undergone his life-changing surgery, Steve is now resting for twelve weeks under the strict supervision of RSPCA staff where he is expected to fully recover. 

RSPCA Inspector Grace Harris-Bridge said: ‘Poor Steve was in a huge amount of pain from his broken leg and was just left alone tied to a bus stop.

A heartless dog owner abandoned his lurcher Steve leaving him tied to a bus stop with a broken leg 

A heartless dog owner abandoned his lurcher Steve (pictured) leaving him tied to a bus stop with a broken leg

A heartless dog owner abandoned his lurcher Steve (pictured) leaving him tied to a bus stop with a broken leg

A heartless dog owner abandoned his lurcher Steve (pictured) leaving him tied to a bus stop with a broken leg

‘It’s absolutely heart-breaking to think someone just discarded him when he was so in need of help.

‘My colleagues at Harmsworth Animal Hospital have also done an incredible job repairing his leg and treating him.’

Staff have tried to identify his owner but haven’t been able to because he doesn’t have a microchip.  

Steve was then moved to an RSPCA hospital for an operation to fix his front leg

Steve was then moved to an RSPCA hospital for an operation to fix his front leg

Having undergone his life-changing surgery, Steve is now resting for twelve weeks under the strict supervision of RSPCA staff where he is expected to fully recover

Having undergone his life-changing surgery, Steve is now resting for twelve weeks under the strict supervision of RSPCA staff where he is expected to fully recover

Steve was then moved to an RSPCA hospital for an operation to fix his front leg. Pictured: Steve’s X-ray

RSPCA Inspector Grace Harris-Bridge said: 'Poor Steve was in a huge amount of pain from his broken leg and was just left alone tied to a bus stop.' Pictured: Steve's X-ray

RSPCA Inspector Grace Harris-Bridge said: 'Poor Steve was in a huge amount of pain from his broken leg and was just left alone tied to a bus stop.' Pictured: Steve's X-ray

RSPCA Inspector Grace Harris-Bridge said: ‘Poor Steve was in a huge amount of pain from his broken leg and was just left alone tied to a bus stop.’ Pictured: Steve’s X-ray

They are now making preparations to find Steve a new home where he can get the love he deserves once he has recovered from his surgery.

Ms Harris-Bridge added: ‘I understand he wasn’t the best patient and understandably seemed very scared and anxious by everything happening.

‘Happily now he has had his operation he’s doing very well and is actually a real sweetie.’

This post first appeared on dailymail.co.uk

Continue Reading

Trending

Copyright © 2020 DiazHub.